Feasibility-related characteristics | Included sample | Never Citers | Indirect Citers | Citers | ||||
---|---|---|---|---|---|---|---|---|
N = 367 | N = 129 | N = 71 | N = 167 | |||||
N | Percent (%) | N | Percent (%) | N | Percent (%) | N | Percent (%) | |
Feasibility indicators | ||||||||
 Recruitment | 281 | 76.6 | 91 | 70.5 | 47 | 66.2 | 143 | 85.6 |
 Retention | 278 | 75.8 | 80 | 62.0 | 51 | 71.8 | 147 | 88.0 |
 Acceptability | 262 | 71.4 | 64 | 49.6 | 50 | 70.4 | 148 | 88.6 |
 Adverse events | 163 | 44.4 | 42 | 32.6 | 28 | 39.4 | 93 | 55.7 |
 Attendance | 66 | 17.9 | 11 | 8.5 | 8 | 11.3 | 47 | 28.1 |
 Compliance | 61 | 16.6 | 18 | 13.9 | 14 | 19.7 | 29 | 17.4 |
 Cost | 39 | 10.6 | 6 | 4.7 | 3 | 4.2 | 30 | 17.9 |
 Data collection | 56 | 15.3 | 9 | 6.9 | 5 | 7.0 | 42 | 25.2 |
 Treatment fidelity | 136 | 37.1 | 20 | 15.5 | 20 | 28.2 | 96 | 57.5 |
Total outcomes reported | ||||||||
 0 | 57 | 15.5 | 40 | 31.0 | 12 | 16.9 | 5 | 2.9 |
 1 | 75 | 20.4 | 39 | 30.2 | 20 | 28.2 | 16 | 9.6 |
 2 | 93 | 25.3 | 27 | 20.9 | 24 | 33.8 | 42 | 25.2 |
 3 | 71 | 19.4 | 17 | 13.2 | 3 | 4.2 | 51 | 30.5 |
 4 or more | 71 | 19.4 | 6 | 4.7 | 12 | 16.9 | 53 | 31.7 |
Feasibility-related characteristics | ||||||||
 Title includes feasibility-related language | 279 | 76.0 | 93 | 72.0 | 46 | 64.8 | 140 | 83.8 |
 Feasibility mentioned in purpose statement | 274 | 74.7 | 74 | 57.4 | 46 | 64.8 | 154 | 92.2 |
 Efficacy mentioned in purpose statement | 204 | 55.6 | 81 | 62.8 | 40 | 56.3 | 83 | 49.7 |
 Progression criteria provided | 45 | 12.3 | 2 | 1.6 | 2 | 1.8 | 41 | 24.6 |
 Statistical testing for efficacy | 246 | 67.0 | 112 | 86.8 | 50 | 70.4 | 84 | 50.3 |
 Feasibility framed as primary outcome | 267 | 72.8 | 70 | 54.3 | 44 | 61.9 | 153 | 91.6 |
 Feasibility of the study mentioned in conclusiona | 180 | 74.7 | 62 | 62.0 | 45 | 76.3 | 73 | 89.0 |
 Efficacy of the study mentioned in conclusiona | 134 | 55.6 | 64 | 64.0 | 32 | 54.2 | 38 | 46.3 |
 Caution advised regarding efficacya | 130 | 53.9 | 58 | 58.0 | 36 | 61.0 | 36 | 43.9 |
 Future testing suggesteda | 216 | 89.6 | 95 | 95.0 | 53 | 89.8 | 68 | 82.9 |